0 Комментарии
0 Поделились
2792 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Meningococcal Disease Vaccine Market is Valued at USD 6.60 Billion with a CAGR of 10.0% During the Forecast Period 2029Meningococcal Disease Vaccine Market Analysis and Size Meningococcal disease is an uncommon infection caused by the bacteria Neisseria meningitidis that affects the lining of the brain, spinal cord, and blood. The germs that cause meningococcal disease transmit by saliva or spit, usually through direct contact with sick persons and subsequent contact. Meningococcal septicemia occurs when...0 Комментарии 0 Поделились 1570 Просмотры 0 предпросмотр
- Meningococcal Disease Vaccine Market is Valued at USD 6.60 Billion with a CAGR of 10.0% During the Forecast Period 2029Meningococcal Disease Vaccine Market Analysis and Size Meningococcal disease is an uncommon infection caused by the bacteria Neisseria meningitidis that affects the lining of the brain, spinal cord, and blood. The germs that cause meningococcal disease transmit by saliva or spit, usually through direct contact with sick persons and subsequent contact. Meningococcal...0 Комментарии 0 Поделились 1536 Просмотры 0 предпросмотр
- Meningococcal Vaccine Market Size, Revenue, Trends, Competitive Landscape Study & Analysis, Forecast To 2032The global meningococcal vaccine market size was USD 3.10 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. Increasing prevalence of meningitis and rising investment in new vaccine development are key factors driving the market revenue growth. Additionally, technological advancement in the field is another factor contributing to market revenue...0 Комментарии 0 Поделились 42 Просмотры 0 предпросмотр